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ABSTRACT Earlier calorimetric studies had indicated that despite the absence of a GpC sequence, the self-complementary
octamer d(CGTCGACG) binds strongly to actinomycin D (ACTD) with high cooperativity and a 2:1 drug/duplex ratio. A
subsequent optical spectral study with related oligomers led us to suggest that ACTD may likely stack at the G  C basepairs
of the duplex termini. New findings are reported herein to indicate that despite the lack of complete self-complementarity,
oligomers of d(CGXCGXCG) [X  A or T] motif exhibit unusually strong ACTD affinities with binding constants of roughly 2 
107 M1 and binding densities of 1 drug molecule per strand. The ACTD binding affinity for the corresponding heteroduplex
obtained by annealing these two oligomers is, however, considerably reduced. Although spectroscopic results with related
oligomers obtained by removing, replacing, or appending bases at the termini appear to be consistent with the end-stacking
model, capillary electrophoretic (CE) evidence provides additional insights into the binding mode. CE experiments with the
self-complementary oligomers d(CGAGCTCG) and d(CGTCGACG) revealed contrasting migration patterns in the presence of
ACTD, with mobility retardation and acceleration exhibited by the GpC- and non-GpC-containing octamers, respectively,
whereas the X/X-mismatched d(CGXCGXCG) experienced retardation. These results, along with those of related oligomers,
suggest that ACTD may in fact stack at the duplex stem end of a monomeric hairpin or at the 3-end of dG as a single strand.
The seemingly cooperative ACTD binding and the curved Scatchard plot for the self-complementary d(CGTCGACG) may thus
be attributed to the drug-induced duplex denaturation resulting from strong binding to single strands of d(CGXCGYCG) motif.
Detailed structural information on the ACTD-DNA complexes, however, must await further NMR investigations.
INTRODUCTION
Actinomycin D (ACTD) is an antitumor antibiotic that
contains a 2-aminophenoxazin-3-one chromophore and two
cyclic pentapeptide lactones. This drug has been used clin-
ically for the treatment of highly malignant tumors, such as
Wilms’ tumor (Farber, 1966) and gestational choriocarci-
noma (Lewis, 1972; Schink et al., 1992), and has also been
used in combination with other antitumor agents to treat
high-risk tumors (Newlands et al., 1991; Marina et al.,
1992; Nakamura et al., 1992).
A wealth of information has been compiled regarding the
interaction of ACTD with DNA. It is well known that
ACTD prefers duplex DNA and binds via intercalation of
the planar chromophore, preferably at the GpC sequence,
with the two pentapeptide rings resting on the minor groove
(see the schematic drawing of Fig. 1 A). A model of DNA-
ACTD complex has been generally accepted in which the
phenoxazone ring is intercalated between the G  C and C 
G basepairs (where guanine residues are on opposite
strands), forming strong hydrogen bonds in the minor
groove between the guanine 2-amino groups and the car-
bonyl oxygen atoms of the L-threonine residues of the
cyclic pentapeptides (Sobell et al., 1971; Sobell and Jain,
1972). Additional stabilizations are derived from hydropho-
bic interactions between groups on the pentapeptides and
sugar residues, and from other specific weaker hydrogen
bonds (Kamitori and Takusagawa, 1992, 1994). Because the
pentapeptide rings of this drug span 4–5 basepairs the
binding affinity of ACTD is expected, and indeed was
found, to be affected by adjacent and neighboring bases
(Scramrov and Beabealashivilli, 1983; Goodisman et al.,
1992; Chen, 1988, 1992).
However, there have been recent reports to indicate that
ACTD may also bind strongly via some non-classic modes,
such as to single-stranded DNA (Wadkins and Jovin, 1991;
Hsieh et al., 1994; Wadkins et al., 1996, 1998) and to some
DNA sequences containing no GpC site (Rill et al., 1989;
Snyder et al., 1989; Bailey et al., 1994; Rill and Hecker,
1996). In particular, calorimetric studies by Snyder et al.
(1989) have indicated that despite the absence of a GpC
sequence ACTD can bind cooperatively to the octamer
d(5CGTCGACG3) with a binding constant on the order of
107 M1 and a 2:1 drug/duplex stoichiometry. Further optical
evidence from this laboratory led us (Chen and Liu, 1996) to
postulate that ACTD may in fact stack on the G  C basepairs
at both ends of this oligomeric duplex (see schematic drawing
of Fig. 1 B). This was based on the rationale that the classic
intercalative preference of ACTD for 5G3p5C3 implies that
the drug favors the 3 side of dG.
Further studies in this laboratory have led to new findings
that despite the lack of complete self-complementarity and the
absence of GpC sequence, octamers d(5CGTCGTCG3) and
d(5CGACGACG3) also bind tightly to ACTD. In an attempt
to understand the nature and to delineate the origin of such a
strong binding, studies were made with these and related
oligomers using capillary electrophoretic and various spectro-
Received for publication 18 January 2000 and in final form 26 June 2000.
Address reprint requests to Dr. Fu-Ming Chen, Department of Chemistry,
Tennessee State University, Nashville, TN 37209-1561. Tel.: 615-963-
5325; Fax: 615-963-5434; E-mail: fchen@tnstate.edu.
© 2000 by the Biophysical Society
0006-3495/00/10/2095/10 $2.00
2095Biophysical Journal Volume 79 October 2000 2095–2104
scopic techniques. The results of these experiments and their
significance are presented and discussed in this report.
MATERIALS AND METHODS
Synthetic oligonucleotides were purchased from Research Genetics
(Huntsville, AL) and used without further purification. These oligomers
were purified by the vendor via reverse-phase oligonucleotide purification
cartridges and exhibited single-band electrophoretic mobilities in denatur-
ing polyacrylamide gel electrophoresis with stated purity of 95%. Con-
centrations of the DNA solutions (in nucleotide) were determined by
measuring the absorbances at 260 nm after melting and calculating the
concentrations by Beer’s law. The extinction coefficients of DNA were
obtained via nearest-neighbor approximation using mono and dinucleotide
values tabulated in Fasman (1975). Heteroduplex formation was accom-
plished by mixing equimolar amounts of the two complementary oli-
gomers, heating the mixture to 95°C for 5 min, and slowly cooling it back
to room temperature. ACTD and 7-amino-ACTD were purchased from
Serva (Hauppauge, NY). Concentrations of the drug solutions were deter-
mined by measuring the absorbances at 440 nm (for ACTD) and 528 nm
(for 7-amino-ACTD), using extinction coefficients of 24,500 and 23,600
cm1 M1, respectively. Stock solutions for oligonucleotides and drugs
were prepared by dissolving in 10 mM Tris-borate buffer solution of pH 8
containing 0.1 M NaCl and 1 mM MgCl2. Absorption spectra were mea-
sured with a Cary 1E spectrophotometric system. Data were collected from
600 to 350 nm. Absorption spectral titrations were carried out by starting
with a 5 M ACTD solution of 2 ml followed by progressive additions of
the oligomer stock at equal time intervals. Absorbance differences between
427 and 480 nm during absorption spectral titrations were used to obtain
the binding isotherms and Scatchard plots. The binding parameters were
deduced via linear least-squares fits on the linear portions of the Scatchard
plots. The bound extinction coefficients were estimated through extrapo-
lations to high DNA concentrations. Circular dichroic (CD) spectra were
measured at room temperature with a Jasco J-500A recording spectropo-
larimeter using water-jacketed cylindrical cells of 2-cm pathlength. The
data were collected from 350 to 230 nm with a scan speed of 50 nm/min.
The CD difference spectra were obtained by subtracting out the spectra of
40 M oligomers (per nucleotide) from those in the presence of 7 M
ACTD. Fluorescence spectra were obtained at 20°C with an SLM 48000S
system. Emission spectra were measured in the region of 580–780 nm with
FIGURE 1 Schematic drawings of intercalative binding mode of ACTD at the GpC site (A) and the earlier proposed end-stacking binding mode of ACTD
to d(CGXCGYCG) (B).
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560 nm excitation, whereas excitation spectra were taken in the region of
420–600 nm with 650 nm emission monitoring.
Capillary electrophoretic experiments were carried out with a Beckman
P/ACE 5000 instrument. Capillary electrophoresis oligonucleotide run
buffer and 75 m ID  375 m OD capillaries internally coated with
poly(AAEE) were purchased from Bio-Rad (Hercules, CA). Samples were
loaded by pressure for 10 s and run at 15 kV and 25°C with 254 nm
absorbance detection. The sieving buffer was replenished before each run
using a 5-min purge cycle at 20 p.s.i. pressure. Two water rinse cycles were
used to remove residual buffer from the capillary and electrode surfaces to
prevent buffer carryover into the sample vial.
RESULTS
Unusually strong ACTD binding of d(CGACGACG)
and d(CGTCGTCG)
Representative absorption spectral alterations during a typ-
ical titration are illustrated with the ACTD  d(CGAC-
GACG) system, and are shown in Fig. 2 A. ACTD exhibits
an absorption maximum near 440 nm in buffer solutions and
without the presence of DNA. Progressive additions of
DNA oligomeric stock result in considerable hypochromic
effects of this band and slight bathochromic shifts to result
in small hyperchromic effects around 480 nm. The observed
hyperchromic effects near 480 nm, however, are signifi-
cantly less than those observed in ACTD titrations with
GpC-containing oligomers (Chen, 1988, 1992). Absorbance
differences between 427 and 480 nm were used to construct
the binding isotherms and some representative Scatchard
plots are shown in Fig. 2, B–D. Most of the plots appear to
be approximately linear and the extracted binding parame-
ters via linear least-squares fits along with some melting
results are summarized in Tables 1-3. It is apparent that
despite the absence of a GpC sequence and complete self-
complementarity, both d(5CGTCGTCG3) and d(5CGA-
CGACG3) bind strongly to ACTD with binding constants
FIGURE 2 (A) Typical spectral alterations during absorption spectral titrations as illustrated by the ACTD d(CGACGACG) system. [nucleotide]/[drug]
ratio is designated by P/D. (B) Comparison of Scatchard plots for ACTD binding to d(CGXCGXCG) and oligomers derived via end base replacement, as
typified by X T series. (C) Comparison of Scatchard plots for d(CGXCGXCG) and oligomers derived via appending base(s) at the terminal(s), as typified
by X  A series. (D) Comparison of Scatchard plots for d(CGXCGXCGXCG) and some related oligomers, as typified by X  T series. Spectral titrations
were carried out at 20°C and the absorbance differences between 427 and 480 nm were used to obtain the binding isotherms. [Bound drug]/[DNA,
nucleotide] is designated by r, and m represents the free drug concentration (in M).
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of 2.5  107 and 1.7  107 M1, respectively, and with
binding densities of 1 drug molecule per strand. The
strong ACTD binding affinities are also evidenced by huge
melting temperature increases upon ACTD binding. In the
absence of ACTD, these two octamers do not exhibit coop-
erative melting above 20°C at 40 M nucleotide concen-
trations and 0.1 M NaCl. However, dramatic ACTD-in-
duced duplex stabilization resulted in melting temperatures
of 65 and 66°C for the drug complexes of d(CGTCGTCG)
and d(CGACGACG), respectively, exhibiting increases of
45°C (see Table 2).
Replacement or removal of end bases results in
considerably weaker ACTD binding affinity
The ACTD binding parameters for the parent octamers and
oligomers derived from replacing the end bases of
d(5CGTCGTCG3) and d(5CGACGACG3) are com-
pared in Table 1, and some representative Scatchard plots
are shown in Fig. 2 B. More than an order of magnitude
reduction in the binding affinities is seen for these end
base-replaced oligomers. For example, d(5GGTCGTCC3)
and d(5GGACGACC3) exhibit binding constants of 1.5
106 and 0.6  106 M1, as compared to 2.5  107 and
1.7 107 M1 for the parent octamers d(5CGTCGTCG3)
and d(5CGACGACG3), respectively. A similar reduction
in the ACTD binding affinity is seen with the removal of
terminal bases from both ends to result in hexamers of the
form d(5GXCGXC3) or with the removal of an XCG unit
from the parent octamers to result in pentamers of the form
d(5CGXCG). Binding constants of 7  105 M1 were
obtained for these oligomers that are more than an order of
magnitude weaker than those of the parent octamers. Hex-
amers of the form d(5CXCGXG3), with somewhat altered
sequence but containing C, G bases at the respective 5 and
3 ends, did not appear to improve the ACTD binding
affinity.
Appending bases at sequence termini results in
somewhat reduced binding affinities
Binding parameters for oligomers obtained by appending
dA and/or dT to the 5 and/or 3 end(s) are compared in
Table 2, and the representative Scatchard plots are shown in
Fig. 2 C. Although the binding affinities of the single
base-appended oligomers are somewhat diminished from
the parent oligomers, their binding strengths are still quite
substantial. Addition of a dT at the 5 or 3 end of
d(5CGTCGTCG3) resulted in a binding constant of 1.3 
107 or 1.5  107 M1, respectively, a slight decrease from
that of 2.5  107 M1 of the parent octamer. Similarly,
addition of dA at the 5 or 3 end of d(5CGACGACG3)
resulted in a binding constant of 0.4 or 1.1  107 M1,
respectively, which is to be compared with 1.7  107 M1
of the parent octamer. Oligomers with bases appended at
both ends exhibit further reduction (at least 2-fold) in bind-
ing affinities from the corresponding single base-appended
oligomers, with binding constants now ranging from 1.7 to
5  106 M1.
ACTD also binds strongly to
d(5CGTCGTCGTCG3) and
d(5CGACGACGACG3) with 1:1
drug/strand ratios
Binding studies with 11-mers d(5CGTCGTCGTCG3) and
d(5CGACGACGACG3) and some related oligomers were
TABLE 2 Comparison of ACTD binding parameters at 20°C
for d(5CGXCGXCG3) and related oligomers via appending
base(s) at the terminal(s)
Oligomer K (M1) n/Strand T°m (°C) Tm (°C)
CGTCGTCG 25 	 2 1.0 	 0.1 
20 65
CGACGACG 17.2 	 0.7 0.9 	 0.1 
20 66
CGTCGTCG[d] 3.1 	 0.1 1.1 	 0.1 41 66
CGTCGTCG-T 15 	 1 0.9 	 0.1 
20 68
A-CGACGACG 4.1 	 0.1 1.1 	 0.1 20 62
CGTCGTCGT[d] 0.7 	 0.1
T-CGTCGTCG 13 	 2 0.7 	 0.1 20 65
CGACGACG-A 10.5 	 0.4 1.1 	 0.1 
20 68
T-CGTCGTCG[d] 0.5 	 0.1
A-CGTCGTCG-T 4.5 	 0.1 1.0 	 0.1
A-CGACGACG-T 1.7 	 0.1
A-CGTCGTCG-T[d] 0.9 	 0.1
T-CGTCGTCG-A 5.04 	 0.01 1.1 	 0.1
T-CGACGACG-A 3.83 	 0.09 1.0 	 0.1
T-CGTCGTCG-A[d] 0.4 	 0.1
Tm° and Tm designate the estimated (	0.5°C) melting temperatures of 40
M DNA (nucleotide) in the absence and in the presence of 7 M ACTD,
respectively. Absorbance changes on melting were monitored at 275 nm.
Heteroduplex is designated by [d].
TABLE 1 Comparison of ACTD binding parameters at 20°C
for d(CGXCGXCG) and some related oligomers via
replacement or removal of end base(s)
Oligomer K (M1) n/Strand
CGTCG 0.8 	 0.1
GTCGTC 0.7 	 0.1
CTCGTG 
0.3
CGTCGTCG 25 	 2 1.0 	 0.1
GGTCGTCC 1.5 	 0.1
TGTCGTCA 1.7 	 0.1
AGTCGTCT 1.8 	 0.1
CGACG 0.7 	 0.1
GACGAC 0.7 	 0.1
CACGAG 
0.3
CGACGACG 17.2 	 0.7 0.9 	 0.1
GGACGACC 0.6 	 0.1
TGACGACA 0.9 	 0.1
AGACGACT 0.5 	 0.1
Parent octamers are designated by bold-face.
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also made, and the results are compared in Table 3; the
representative Scatchard plots are shown in Fig. 2 D. These
two 11-mers are obtained by adding one additional XCG
unit to the corresponding parent octamers. It is apparent that
both of these 11-mers exhibit strong ACTD binding with
roughly 2  107 M1 in binding constant, comparable to
those of the corresponding parent octamers. Most interest-
ingly, the extracted binding densities are also 1 drug
molecule per strand, same as those of the parent octamers.
Again, appending the oligomers with dA and/or dT reduces
the binding affinities somewhat. The strong ACTD affinities
are further supported by dramatic melting temperature in-
creases of roughly 44°C upon ACTD binding (see Table 3).
Binding affinities for the corresponding
heteroduplexes are considerably reduced
The parent octamers d(5CGTCGTCG3) and d(5CGACG-
ACG3) are in fact complementary to each other. Thus,
mixing equal molar amounts of the two oligomers will
result in a predominantly heteroduplex formation at 20°C.
Interestingly, the ACTD binding ability of the heteroduplex
is considerably diminished. The binding constant obtained
via Scatchard plot yielded a value of 3.1  106 M1 for the
heteroduplex, contrasting those of roughly 2  107 M1 for
the component strands. Similar reductions in the binding
affinity of nearly an order of magnitude for the heterodu-
plexes are also observed for the base-appended oligomers
(see Table 2). The diminished ACTD binding ability of the
heteroduplex as compared to the constituent oligomers is
even more dramatically illustrated by the 11-mers in which
the corresponding heteroduplex exhibits a binding affinity
of 3  105 M1 as compared to those of 2  107 M1 for
the component oligomers, a reduction of nearly two orders
of magnitude (see Table 3). The importance of proximal
basepair mismatches on ACTD binding is further investi-
gated by replacing those mismatches with basepairs and
leaving only a single T/T mismatch at the center. The ACTD
FIGURE 3 Comparison of ACTD-induced CD spectral characteristics at room temperature for d(CGTCGTCGTCG), its heteroduplex, and some related
oligomers. Spectra were measured at room temperature using a cylindrical cell of 2-cm pathlength with 40 M (base) of oligonucleotide in the absence
and in the presence of 5 M ACTD. Difference CD spectra were obtained by subtracting out the contribution due to DNA.
TABLE 3 Comparison of ACTD binding parameters for
d(5CGXCGXCGXCG3) and related oligomers at 20°C
Oligomer K (M1) n/Strand T°m (°C)
Tm
(°C)
CGTCGTCGTCG 21 	 3 1.1 	 0.1 32 76
CGACGACGACG 20 	 1 1.1 	 0.1 28 78
CGTCGTCGTCG[d] 0.3 	 0.1 56 75
CGTCGTCGACG 4.2 	 0.1 1.1 	 0.1 40 78
CGACGTCGTCG 1.4 	 0.1 52 77
CGTCGTCGTCG-T 14 	 1 1.0 	 0.1
A-CGACGACGACG 2.0 	 0.1
A-CGACGACGACG[d] 1.5 	 0.1
T-CGTCGTCGTCG 13 	 1 1.2 	 0.1
CGACGACGACG-A 11.7 	 0.8 1.0 	 0.1
T-CGTCGTCGTCG[d] 
0.2
Tm° and Tm designate the estimated (	0.5°C) melting temperatures of 40
M DNA (nucleotide) in the absence and in the presence of 7 M ACTD.
Absorbance changes on melting were monitored at 275 nm. Heteroduplex
is designated by [d].
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binding affinities for the resulting 11-mers d(5CGTCGTC-
GACG3) and d(5CGACGTCGTCG3) are seen to be smaller
and larger than the corresponding three X/X-mismatched
d(5CGXCGXCGXCG3)andfullybasepairedd(5CGXCGX-
CGXCG3)[d], respectively (see Table 3 and Fig. 2 D).
CD measurements support the results of
equilibrium binding titrations
Binding of ACTD to DNA can induce a characteristic CD
spectrum consisting of positive and negative maxima near
293 and 270 nm, respectively. Thus, it is possible to obtain
relative ACTD binding affinities qualitatively by comparing
the induced CD intensities at 293 nm. CD difference spec-
tral comparison (ACTD/DNA-DNA) of d(5CGTCGTCG-
TCG3) and its heteroduplex, along with those of d(CGTCGT-
CGACG) and d(CGACGTCGTCG), are illustrated in Fig. 3.
The last two oligomers are essentially self-complementary
except for the dT at the center. In agreement with the results of
absorbance binding titrations, d(5CGTCGTCGTCG3) exhib-
its a considerably larger CD intensity at 293 nm than its
heteroduplex, while the two nearly self-complementary 11-
mers are intermediate of these two extremes.
CD measurements were also extended to cover the
460-nm spectral region. In contrast to the GpC containing
oligomers, ACTD binding to both d(CGACGACG) and
d(CGTCGTCG) induces positive rather than negative CD in
this region.
Comparison with the fluorescence results of
7-amino-ACTD
Unlike ACTD, the fluorescence of its 7-amino derivative
(7-amino-ACTD) is quite substantial. It is thus of interest to
corroborate the ACTD results with those of this derivative
via fluorescence measurements because its 7-amino group
substitution has been shown not to greatly alter the interca-
lative binding nature of this derivative. The binding of
7-amino-ACTD with DNA usually results in an enhanced
fluorescence emission spectrum exhibiting a maximum near
650 nm and a fluorescence intensity enhancement near 540
nm in the excitation spectrum with 650-nm emission mon-
itoring. Difference fluorescence excitation spectra (drug/
DNA–drug), as typified by d(CGTCGTCG) and related
oligomers, are compared in Fig. 4. Consistent with the
weaker ACTD binding affinities, the double base-appended
oligomers exhibit somewhat lower fluorescence intensities
than those of the single base-appended ones, whereas all the
base-appended oligomers induce significantly stronger flu-
orescence than the parent octamers.
Capillary electrophoretic profiles
Capillary electropherograms of d(CGTCGTCG), d(CGTC-
GACG), and d(CGAGCTCG) in the absence (lower trace of
each panel) and in the presence of ACTD (upper trace of
each panel) are compared in Fig. 5. Consistent with a
FIGURE 4 Comparison of difference (drug/DNA–drug, with appropriate concentration corrections) fluorescence excitation spectra of 7-amino-ACTD
as induced by d(CGTCGTCG) and related oligomers derived from appending base(s) at the terminal(s). Spectra were measured with 2 M 7-amino-ACTD
in the presence of 40 M nucleotide at 20°C with 650-nm monitoring of fluorescence emission.
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FIGURE 5 Comparison of capillary electropherograms at 25°C for d(CGAGCTCG) (bottom), d(CGTCGACG) (middle), and d(CGTCGTCG) (top) in
the absence (lower trace) and in the presence (upper trace) of 0.8 M ACTD in the running buffer. DNA concentrations are roughly 0.8 mM in nucleotide.
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single-stranded conformation at room temperatures, the oc-
tamer with T/T mismatches exhibits a considerably shorter
migration time than those of the two self-complementary
octamers, which exist mainly in the duplex form at room
temperature (compare lower traces of the three panels). It is
interesting that binding of ACTD resulted in distinctly dif-
ferent migration patterns for these oligomers. The self-
complementary octamer d(CGAGCTCG) contains a central
GpC site, and thus an ACTD molecule is expected to be
intercalated at that location. Indeed, in the presence of
ACTD in the running buffer, the electrophoretic mobility of
the oligomer is retarded to result in a slower migration time
(see the lower panel). In contrast, the binding of ACTD to
the non-GpC-containing octamer d(CGTCGACG) resulted
in a considerably faster migration time. Interestingly, a mod-
erate retardation of electrophoretic mobility was observed for the
T/T-containing d(CGTCGTCG) upon ACTD binding. CE results
of these three oligomers are summarized in Table 4.
DISCUSSION
Despite the absence of a strong binding GpC sequence and
the lack of complete self-complementarity, both d(CGAC-
GACG) and d(CGTCGTCG) exhibit unusually strong
ACTD binding affinities of roughly 2 107 M1 in binding
constant and 1 drug molecule per DNA strand in binding
density. In contrast to the previously studied self-comple-
mentary counterparts (Snyder et al., 1989; Chen and Liu,
1996), the Scatchard plots for ACTD binding to d(CGX-
CGXCG) do not exhibit unusual curvatures. Melting exper-
iments indicate that the melting temperatures of the X/X-
mismatched octamers are below 20°C, whereas the ACTD-
bound complexes melt around 65°C, the same as those of
self-complementary counterparts. Interestingly, the ACTD
binding propensity of the heteroduplex formed by annealing
these two oligomers together is considerably diminished.
Removing as well as replacing the end bases resulted in a
diminution of the ACTD binding strength by more than an
order of magnitude. A slight reduction in the binding affin-
ity for oligomers with a single-base terminal addition and a
further reduction in the binding affinity upon a terminal A 
T basepair addition were also observed. These results are
similar to those found for the self-complementary octamer
d(CGTCGACG) and appear not to contradict our earlier
speculation that drug molecules stack at the terminal G  C
basepairs of the duplex (Chen and Liu, 1996). Furthermore,
addition of an XCG unit to the parent octamers resulted in
no apparent reduction in binding affinities, and the binding
densities remained1 drug molecule per strand. Analogous
to their parent octamers, more than an order of magnitude
reduction in the binding strength is seen for the annealed
heteroduplex of these 11-mers. The finding that the binding
densities of 1 drug molecule per strand is maintained for the
ACTD binding to the d(CGXCGXCGXCG) oligomers, de-
spite a 3-base addition to the parent octamers, is consistent
with an end-binding model because if the binding were to be
at the internal sequences, the binding densities for the 11-
mers would have been significantly increased.
The results of CD and fluorescence spectral measure-
ments also appear to conform with the notion of end-
stacking binding mode. Appending base(s) at one or two
end(s) results in reduced CD intensities at 293 nm, and the
resulting rankings are consistent with the relative binding
affinities obtained via absorption spectral titrations. In con-
trast to binding of ACTD to GpC-containing oligomers, a
positive CD intensity results in the 460-nm region upon
binding to d(CGACGACG) or d(CGTCGTCG), similar to
that of binding to the mononucleotide pdG (Hommer,
1969). This strongly implicates the stacking of drug at the
terminal dG. Despite the fact that the extents of fluorescence
enhancement of 7-amino-ACTD do not exactly correlate
well with the binding order for the oligomers studied, it is
apparent that changing the end bases of a sequence greatly
affects the fluorescence intensities induced. The fluores-
cence results, however, appear to provide rather convincing
evidence that the binding of ACTD to d(CGXCGXCG)
occurs at the termini rather than at the internal sequences. If
the binding were to occur at the internal sequences, changes
at the sequence ends would not be expected to make a
significant influence on the fluorescence spectral character-
istics of the bound drug. However, the fluorescence results
clearly indicate that when dangling bases were added at one
or two sequence ends, strong fluorescence enhancements
were observed. The somewhat reduced fluorescence en-
hancements for oligomers with dangling bases on both ends
as compared to the corresponding oligomers with a single
dangling base most likely resulted from significant reduc-
TABLE 4 Comparison of capillary electrophoretic profiles at
25°C for d(5CGTCGTCG3) and related oligomers in the
presence and in the absence of ACTD
Oligomer
[ACTD]
in DNA
(M)
[ACTD] in
buffer (M) t (min)*
d(CGAGCTCG) 0.00 0.00 3.94
0.0 40 4.03
0.25 40 3.84, 4.53
0.50 40 4.48
0.75 40 4.53
d(CGTCGACG) 0.00 0.00 3.98
0.0 40 3.89
0.25 40 3.39
0.50 40 3.16
0.75 40 3.02
d(CGTCGTCG) 0.00 0.00 2.52
0.0 40 2.52
0.25 40 2.65
0.50 40 2.74
0.75 40 2.75
*t is the migration time (	0.02 min) relative to that of dT, which was
added as an internal reference.
2102 Sha and Chen
Biophysical Journal 79(4) 2095–2104
tion in binding affinities (at least 2-fold) due to the extra
added base, which more than compensated for the expected
further intensity increase.
The interpretation of ACTD stacking at the duplex ter-
mini, however, begs the question as to why the heteroduplex
formed by annealing d(CGTCGTCG) and d(CGACGACG)
exhibits a dramatic reduction in ACTD binding affinity.
One could argue that this may be the consequence of the
fact that an optimal ACTD binding via stacking on a ter-
minal G  C basepair requires not only strong hydrogen-
bonding of the drug with the basepair, but also a snug fit for
one of the pentapeptide rings in the minor groove. Because
of its somewhat more rigid structure, it would be more
difficult for a fully basepaired duplex to achieve an optimal
fit than a duplex with a proximal basepair mismatch because
the former would be less accommodating to the drug’s side
chains. Such a rationale would have been in line with the
significant reduction in ACTD binding affinities of
d(CGTCGTCGACG) and d(CGACGTCGTCG), where the
two outer T/T mismatches have been replaced by A  T
pairs, to 4.2 and 1.4  106 M1, respectively, from that of
2.1  107 M1 for the parent 11-mer d(CGTCGTCGTCG).
The fully basepaired heteroduplex d(CGTCGTCGTCG)[d]
showed further reduction, with a binding constant of merely
3  105 M1.
Additional insights into the binding mode, however, are
provided by the intriguing and contrasting capillary electro-
phoretic migration patterns of d(CGAGCTCG) and
d(CGTCGACG) with and without ACTD. Although the
distinct electrophoretic behaviors are consistent with their
differing binding modes, it is somewhat puzzling that an
ACTD intercalation at the central GpC site resulted in a
mobility retardation for d(CGAGCTCG), whereas binding
of d(CGTCGACG), presumably stacking at duplex termini,
resulted in a faster migration. Interestingly, the CE migra-
tion patterns of the T/T-mismatched octamer d(CGTCG-
TCG) appear to provide a possible resolution. The consid-
erably faster mobility of d(CGTCGTCG) in the absence of
ACTD as compared to the two self-complementary octam-
ers suggests that this oligomer exists predominantly in the
single-stranded or monomeric hairpin form, and its mobility
retardation in the presence of ACTD is consistent with drug
binding to form a complex of higher molecular weight.
Thus, the seemingly anomalous accelerated mobility upon
ACTD binding to the self-complementary d(CGTCGACG)
may be interpreted to be a result of drug-induced denatur-
ation, a consequence of ACTD binding to the higher-affin-
ity single-stranded or hairpin form to result in complexes
exhibiting higher mobility than their corresponding duplex.
This would explain the significant reduction of ACTD bind-
ing affinity of the heteroduplex when compared to its con-
stituent oligomers, because the stronger-binding single
strands have now been largely tied up in the duplex forma-
tion. Consequently, the duplex formation adversely affects
its ACTD binding.
In view of the proposed single-strand binding, the ab-
sence of curvatures in the Scatchard plots for octamers
d(CGXCGXCG) and the apparent presence of curvature in
the Scatchard plots for the previously studied self-comple-
mentary octamers d(CGTCGACG) and d(CGACGTCG)
may be worthy of comment. The presence of X/X mis-
matches in d(CGXCGXCG) dictates that at room tempera-
ture the oligomers exist predominantly in the single-
stranded form that binds strongly to ACTD, thus the
absence of unusual Scatchard plots. However, the self-
complementary octamers d(CGTCGACG) and d(C-
GACGTCG) should exist predominantly in the duplex form
and an ACTD-induced denaturation would be needed to
provide single strands for binding and, thus, result in a
curvature in the Scatchard plots with seeming binding co-
operativity. The nearly identical melting temperatures of the
ACTD complexes, regardless of whether they are formed
with self-complementary or mismatched octamers, also ap-
pear plausible under the single-strand binding model, as the
resulting complexes are similar. The huge melting temper-
ature increases of 45°C upon ACTD binding to the mis-
matched oligomers, however, seemed rather unusual. The
increase of such a magnitude would have generally corre-
sponded to a binding affinity of at least an order of magni-
tude higher than the 107 M1 obtained via our titrations.
Such an argument would be correct if the dominant confor-
mation of the DNA in the absence of drugs is the one
directly involved in the drug binding. It is plausible that the
conformation of d(CGXCGXCG) responsible for ACTD
binding may be induced by the drug or exists initially as a
minor form (thus exhibits no detectable cooperative melting
temperature) rather than the dominant contributor to the
DNA conformations in the absence of drugs. A quantitative
correlation of the melting temperature increases with the
drug binding constants will, consequently, not be as straight
forward.
In contrast to the XCG addition, pentamers d(CGXCG)
resulted from the removal of an XCG unit from the parent
octamer exhibit more than an order of magnitude lower
ACTD affinities. This suggests that in addition to the se-
quence and the presence of G at the 3 terminal, a minimum
length of 8 bases may be essential for strong ACTD binding
for oligomers with XCG motif. This appears to be consistent
with the formation of intramolecular DNA conformation,
such as hairpin, during the ACTD complexation. The weak
bindings of hexamers d(GXCGXC) and d(CXCGXG) may
thus be attributed to the shorter length and the altered
sequence of the latter, and the absence of G at the 3
terminal for the former.
To further delineate the binding contributions of hairpin
versus single-stranded forms, detailed NMR structural stud-
ies of ACTD complexes with d(CGTCGTCG) will be
needed. These studies are currently underway at the labo-
ratory of Dr. Shan-Ho Chou, and the results will be reported
as they become available.
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